AbbVie price target raised to $220 from $214 at BMO Capital
Oct 18, 2024 · BMO Capital raised the firm’s price target on AbbVie to $220 from $214 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results …
OFF
AbbVie Price Target Raised To $220 From $214 At BMO Capital
1 week from now
Oct 18, 2024 · BMO Capital raised the firm’s price target on AbbVie to $220 from $214 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results …
yahoo.com
OFF
AbbVie (NYSE:ABBV) Price Target Increased To $220.00 By Analysts …
1 week from now
Oct 17, 2024 · AbbVie (NYSE:ABBV - Free Report) had its target price lifted by BMO Capital Markets from $214.00 to $220.00 in a research report report published on Thursday, Benzinga …
marketbeat.com
OFF
AbbVie Price Target Raised To $220 From $214 At BMO Capital
1 week from now
Oct 17, 2024 · BMO Capital raised the firm’s price target on AbbVie to $220 from $214 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results …
tipranks.com
OFF
BMO Capital Adjusts Price Target On AbbVie To $220 From $214
1 week from now
Oct 17, 2024 · -- AbbVie has an average outperform rating and a price target range of $170 to $225, according to analysts polled by Capital IQ. Price: 191.29, Change: +0.82, Percent …
marketscreener.com
OFF
Analysts Revise AbbVie Stock Price Target Ahead Of Earnings - MSN
1 week from now
BMO Capital raised its price target on AbbVie to $220 from $214 and affirmed an outperform rating on the shares as part of a broader research note previewing third-quarter results in …
msn.com
OFF
BMO Capital Maintains Outperform On AbbVie, Raises Price Target …
1 week from now
Oct 17, 2024 · BMO Capital analyst Evan David Seigerman maintains AbbVie (NYSE:ABBV) with a Outperform and raises the price target from $214 to $220.
sahmcapital.com
OFF
AbbVie Inc.: Target Price Consensus And Analysts …
1 week from now
Nov 5, 2024 · BMO Capital Adjusts Price Target on AbbVie to $220 From $214 Oct. 17: MT Truist Securities Adjusts AbbVie Price Target to $215 From $210 Oct. 10: MT UBS Adjusts Price …
marketscreener.com
OFF
AbbVie Inc.: Target Price Consensus And Analysts …
1 week from now
Nov 11, 2024 · BMO Capital Adjusts Price Target on AbbVie to $208 From $228, Maintains Outperform Rating Nov. 12: MT Raymond James Cuts AbbVie Price Target to $218 From …
marketscreener.com
OFF
ABBV - Abbvie Inc Stock Price And Quote - FINVIZ.com
1 week from now
Feb 27, 2015 · Price Target Change; Nov-04-24: Upgrade: Argus: Hold → Buy: Oct-17-24: Initiated: Bernstein: Mkt Perform: $203: ... AbbVie price target raised to $220 from $214 at …
finviz.com
OFF
BMO Capital Markets Issues Pessimistic Forecast For AbbVie …
1 week from now
5 days ago · BMO Capital Markets decreased their price target on shares of AbbVie from $228.00 to $208.00 and set an "outperform" rating for the company in a research note on Tuesday. ...
marketbeat.com
OFF
AbbVie: Balanced Outlook Amid EPS Adjustments And Pipeline ...
1 week from now
Oct 23, 2024 · The associated price target remains the same with $206.00. ... AbbVie price target raised to $195 from $185 at BofA ... AbbVie price target raised to $220 from $214 at BMO …
businessinsider.com
OFF
AbbVie Could Soar 24%, According To A Wall Street Analyst. Is The …
1 week from now
Jul 22, 2024 · BMO Capital analyst Evan Seigerman raised his price target on the stock from $180 to $214 per share on Friday, July 19. Bullishness for AbbVie might seem foolhardy to the …
fool.com
OFF
AbbVie (ABBV) Stock Forecast And Price Target 2024 - MarketBeat
1 week from now
3 days ago · According to the 21 analysts' twelve-month price targets for AbbVie, the average price target is $203.89. The highest price target for ABBV is $225.00, while the lowest price …
marketbeat.com
OFF
ABBV Stock Price Target | AbbVie Analyst Ratings
1 week from now
Sep 29, 2020 · This price target is based on 21 analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $203.89, with a high forecast of …
pricetargets.com
OFF
AbbVie Stock Target Cut, Rating Continued On Trial Results
1 week from now
6 days ago · On Tuesday, BMO Capital Markets adjusted its outlook on AbbVie (NYSE:ABBV) shares by reducing the price target to $208 from the previous $228. The firm has maintained …
investing.com
OFF
AbbVie Price Target Lowered To $208 From $228 At BMO Capital
1 week from now
5 days ago · BMO Capital analyst Evan Seigerman lowered the firm’s price target on AbbVie (ABBV) to $208 from $228 and keeps an Outperform rating on the shares. The firm is citing …
nasdaq.com
OFF
AbbVie, Gedeon Richter Collaborate For Discovery, Development
1 week from now
Oct 24, 2024 · AbbVie price target raised to $220 from $214 at BMO Capital The views and opinions expressed herein are the views and opinions of the author and do not necessarily …
nasdaq.com
FAQs about AbbVie price target raised to $220 from $214 at BMO Capital Coupon?
Should you buy AbbVie (abbv)?
When will AbbVie report quarterly results?
What is the price target for AbbVie (abbv)?
What is Morgan Stanley's target price on AbbVie?
Which sell-side analysts are buying AbbVie (abbv) stock?
Is AbbVie a good stock to buy?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
